Nidan Laboratories And Healthcare Ltd (NIDAN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: NIDAN | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Nidan Laboratories And Healthcare Ltd (NIDAN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: NIDAN | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Nidan Labs. & Health

Based on:

M-Cap below 100cr DeciZen not available

Nidan Laboratories And Healthcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
14.10
Market Cap:
27.9 Cr.
52-wk low:
0
52-wk high:
0

Is Nidan Laboratories And Healthcare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Nidan Labs. & Health: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nidan Laboratories And Healthcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 11.7%10.2%14%10.5%8.5%-0.2%6.2%-
Value Creation
Index
-0.2-0.3-0-0.3-0.4-1.0-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 20.121.420.429.724.324.224.525
Sales YoY Gr.-6.7%-4.8%45.5%-18.2%-0.4%1.5%-
Adj EPS 0.20.72.31.82.411.41.4
YoY Gr.-213%223.6%-24%36.2%-60.6%48.4%-
BVPS (₹) 10.411.113.547.45047.649.149.1
Adj Net
Profit
0.20.72.32.53.41.322
Cash Flow from Ops. 94.64.47.8115.52.3-
Debt/CF from Ops. 3.67.48.82.512.34.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA2.8%-6.1%1.5%
Adj EPS NA14.4%-7.3%48.4%
BVPSNA34.5%1.1%3%
Share Price - - -28.1% -29.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.26.718.96.2522.92.9
Op. Profit
Mgn %
39.135.743.631.72826.720.6NAN
Net Profit
Mgn %
1.13.311.38.313.85.588.1
Debt to
Equity
3.13.12.90.30.20.20.2-
Working Cap
Days
02693835018258687790
Cash Conv.
Cycle
0897839734300

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Nidan Laboratories And Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 1.4 -
TTM Sales (₹ Cr.) 24.5 -
BVPS (₹.) 49.1 -
Reserves (₹ Cr.) 54 -
P/BV 0.41 -
PE 14.10 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 27.9
Equity (₹ Cr.) 13.9
Face Value (₹) 10
Industry PE 90.5

Management X-Ray of Nidan Labs. & Health:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Nidan Labs. & Health - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Nidan Labs. & Health

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales20.0621.4120.3829.6624.2724.1824.53
Operating Expenses 12.2213.7711.4920.2517.4617.7319.47
Manufacturing Costs2.132.421.165.774.926.048.24
Material Costs1.722.552.213.091.091.010.78
Employee Cost 2.352.772.853.594.884.464.36
Other Costs 6.026.045.277.806.576.226.09
Operating Profit 7.847.648.899.416.806.445.06
Operating Profit Margin (%) 39.1%35.7%43.6%31.7%28.0%26.7%20.6%
Other Income 0.370.011.060.403.332.752.25
Interest 4.753.743.462.662.222.182.14
Depreciation 3.243.193.182.633.102.872.41
Exceptional Items 00000-6.510
Profit Before Tax 0.220.713.304.524.81-2.372.76
Tax 0011.861.270.860.78
Profit After Tax 0.220.712.302.663.54-3.231.98
PAT Margin (%) 1.1%3.3%11.3%9.0%14.6%-13.4%8.1%
Adjusted EPS (₹)0.20.72.31.92.6-2.31.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 10.3111.0313.3365.9069.4466.2168.18
Share Capital 9.909.909.9013.9013.9013.9013.90
Reserves 0.411.133.435255.5452.3154.28
Minority Interest0000000
Debt32.1734.3522.9118.139.6611.6610.83
Long Term Debt32.1734.3514.169.424.774.293.90
Short Term Debt008.768.714.897.376.94
Trade Payables0.55-0.181.291.150.210.730.96
Others Liabilities -0.22-0.2415.962.854.613.142.20
Total Liabilities 42.8144.9653.4988.0383.9281.7382.17

Fixed Assets

Gross Block55.3655.3758.3659.7460.6557.6758.44
Accumulated Depreciation32.0835.2638.4539.2839.2639.7242.10
Net Fixed Assets 23.2820.1019.9220.4621.3917.9516.33
CWIP 000.233.8100.040.15
Investments 0.530.530.2700020
Inventories0.080.090.110.220.370.300.55
Trade Receivables5.615.435.435.366.030.521.27
Cash Equivalents 4.347.397.308.108.422.851.90
Others Assets 8.9711.4220.2450.0747.7260.0741.97
Total Assets 42.8144.9653.4988.0383.9281.7382.17

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 8.954.624.357.8310.975.522.28
PBT 0.220.713.304.524.81-2.372.76
Adjustment 7.996.936.554.542.049.192.23
Changes in Working Capital 0.74-3.03-5.51-0.074.151.5-1.11
Tax Paid 000-1.16-0.03-2.80-1.60
Cash Flow From Investing Activity 1-0.01-3.22-35.74-0.29-10.60-0.22
Capex 1-0.01-3.22-6.480.05-0.64-0.87
Net Investments 000000-20
Others 000-29.26-0.34-9.9620.65
Cash Flow From Financing Activity -5.81-1.56-1.2228.72-10.37-0.49-3.01
Net Proceeds from Shares 00049.91000
Net Proceeds from Borrowing -1.062.182.15-18.75-8.361.49-1.20
Interest Paid -4.75-3.74-3.36-2.44-2-1.97-1.81
Dividend Paid 0000000
Others 000-00-0-0
Net Cash Flow 4.143.05-0.100.800.32-5.57-0.95

Finance Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.176.718.96.725.23-4.772.94
ROCE (%)11.7110.1513.9810.528.5-0.246.21
Asset Turnover Ratio0.470.490.410.420.280.290.3
PAT to CFO Conversion(x)40.686.511.892.943.1N/A1.15
Working Capital Days
Receivable Days102949766864913
Inventory Days1122456
Payable Days1162691144227169398

Nidan Laboratories And Healthcare Ltd Stock News

Nidan Laboratories And Healthcare Ltd FAQs

The current trading price of Nidan Labs. & Health on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Nidan Labs. & Health stood at ₹27.87.
The latest P/E ratio of Nidan Labs. & Health as of 31-Dec-1969 is 14.10.
The latest P/B ratio of Nidan Labs. & Health as of 31-Dec-1969 is 0.41.
The 52-week high of Nidan Labs. & Health is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Labs. & Health is ₹24.53 ( Cr.) .

About Nidan Laboratories And Healthcare Ltd

Nidan Laboratories and Healthcare was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 5, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratoris And Healthcare Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the company was converted into a public limited company and the name of the company was changed to ‘Nidan Laboratories And Healthcare Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021.

The company was established as a proprietary Firm in 1994 by its Promoter- Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The business was carried out under sole proprietorship, which was later taken over by the company in 2000. From the year 2000, he expanded the diagnostic’s business by setting up various centre’s within the Northern District of Mumbai and Pune and Southern District of Pune.

Business area of the company

The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×